Pfizer Inc is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said Monday, January 9. Reuters reported on Friday that China was in talks with Pfizer to secure a […]
The post Pfizer CEO says there will be no generic Paxlovid for China appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.
Subscribe to our newsletters now and stay
up-to-date with new articles and exclusive offers.
Your email is safe with us. We won't spam.